The increase in HE4 urinary levels, but not NGAL urinary levels, in the TAC–AKI group suggests that tacrolimus induces AKI by triggering the release of cytokines and chemokines, which exacerbate tubular injury. This evidence concerns the gene WFDC2 and acute kidney injury.